Skip to Main Content

December 19, 2022   

Bringing Value-Based Care to Cancer Treatment Past, Present, and Future

This Briefing is brought to you by AHLA’s Regulation, Accreditation, and Payment Practice Group.
  • December 19, 2022
  • Devin Cohen , Ropes & Gray
  • David Ault , Ropes & Gray
  • Ryan B. Marcus , Ropes & Gray

Value-based care presents a unique set of challenges to oncology practice. A cancer diagnosis is inherently devastating. A family receiving a dire diagnosis is unlikely to focus on reducing costs of care at the onset, instead hoping for all possible interventions to stop the spread of the cancer and achieve remission. With that in mind, cancer affects all parts of the mind and body, and involves the coordination of care between multiple specialists across disciplines and health systems, the number of which can vary dramatically depending on the type of cancer being treated. The resulting expenses can be staggering—the National Cancer Institute estimated costs for cancer care to be $190.2 billion in 2015, rising to $208.9 billion in 2020. By 2030, that number is projected to increase to $246 billion.


You must be logged in to access this content.